[HTML] mdpi.com

[HTML][HTML] CD123 as a therapeutic target in the treatment of hematological malignancies

U Testa, E Pelosi, G Castelli - Cancers, 2019 - mdpi.com
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …
被引用次数：127 相关文章

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies

U Testa, E Pelosi, G Castelli - Cancers, 2019 - pubmed.ncbi.nlm.nih.gov
The interleukin-3 receptor alpha chain (IL-3R), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …
[HTML] mdpi.com

[HTML][HTML] CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies

U Testa, E Pelosi, G Castelli - mdpi.com
The interleukin-3 receptor alpha chain (IL-3R), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.

U Testa, E Pelosi, G Castelli - Cancers, 2019 - europepmc.org
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies

E Pelosi, G Castelli - Cancers, 2019 - search.proquest.com
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …
[HTML] nih.gov

[HTML][HTML] CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies

U Testa, E Pelosi, G Castelli - Cancers, 2019 - ncbi.nlm.nih.gov
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …
[PDF] semanticscholar.org

[PDF][PDF] CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies

U Testa, E Pelosi, G Castelli - pdfs.semanticscholar.org
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.

U Testa, E Pelosi, G Castelli - Cancers, 2019 - search.ebscohost.com
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.

U Testa, E Pelosi, G Castelli - Cancers, 2019 - europepmc.org
The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is
widely overexpressed in various hematological malignancies, including acute myeloid …